UTMD (STOCKS)
Utah Medical Products Inc
$63.730000
-0.470000 (-0.73%)
Prev close: $64.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Kevin Leighton Cornwell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $203.11M
- Employees
- 167
- P/E (TTM)
- 18.30
- P/B (TTM)
- 1.70
- Dividend Yield
- 192.22%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2024 (Q1)
|
$1.09 | $0.00 | +0.0000 | +0.00% |
|
Jun 2023 (Q2)
|
$1.15 | $0.00 | +0.0000 | +0.00% |
|
Dec 2022 (Q4)
|
$1.25 | $0.00 | +0.0000 | +0.00% |
|
Mar 2014 (Q1)
|
$0.72 | $0.81 | -0.0858 | -10.65% |
Financial Statements
| Revenues | $38.63M |
| Benefits Costs and Expenses | $24.73M |
| Cost Of Revenue | $16.57M |
| Costs And Expenses | $24.73M |
| Gross Profit | $22.06M |
| Operating Expenses | $10.20M |
| Research and Development | $577.00K |
| Operating Income/Loss | $11.86M |
| Income/Loss From Continuing Operations After Tax | $11.62M |
| Income/Loss From Continuing Operations Before Tax | $13.91M |
| Income Tax Expense/Benefit | $5.92M |
| Income Tax Expense/Benefit, Deferred | -$583.00K |
| Net Income/Loss | $11.62M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $11.62M |
| Net Income/Loss Available To Common Stockholders, Basic | $11.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.54 |
| Diluted Earnings Per Share | $3.54 |
| Basic Average Shares | 9,724,000 |
| Diluted Average Shares | 9,724,000 |
| Assets | $121.98M |
| Current Assets | $96.53M |
| Inventory | $8.12M |
| Other Current Assets | $88.41M |
| Noncurrent Assets | $25.44M |
| Fixed Assets | $10.00M |
| Intangible Assets | $1.39M |
| Other Non-current Assets | $14.05M |
| Liabilities | $3.72M |
| Current Liabilities | $3.01M |
| Accounts Payable | $768.00K |
| Other Current Liabilities | $2.24M |
| Noncurrent Liabilities | $712.00K |
| Equity | $118.25M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $118.25M |
| Liabilities And Equity | $121.98M |
| Net Cash Flow From Operating Activities | $14.15M |
| Net Cash Flow From Operating Activities, Continuing | $14.15M |
| Net Cash Flow From Investing Activities | -$271.00K |
| Net Cash Flow From Investing Activities, Continuing | -$271.00K |
| Net Cash Flow From Financing Activities | -$18.11M |
| Net Cash Flow From Financing Activities, Continuing | -$18.11M |
| Exchange Gains/Losses | $48.00K |
| Net Cash Flow | -$4.19M |
| Net Cash Flow, Continuing | -$4.23M |
| Comprehensive Income/Loss | $13.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $13.79M |
| Other Comprehensive Income/Loss | $2.17M |